IL234777A - Erythuran or its salts suitable for pharmacological use in the treatment of Orthomix virus infections - Google Patents
Erythuran or its salts suitable for pharmacological use in the treatment of Orthomix virus infectionsInfo
- Publication number
- IL234777A IL234777A IL234777A IL23477714A IL234777A IL 234777 A IL234777 A IL 234777A IL 234777 A IL234777 A IL 234777A IL 23477714 A IL23477714 A IL 23477714A IL 234777 A IL234777 A IL 234777A
- Authority
- IL
- Israel
- Prior art keywords
- eritoran
- pharmaceutically acceptable
- acceptable salts
- treating
- orthomyxovirus infections
- Prior art date
Links
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 title 1
- BPSMYQFMCXXNPC-MFCPCZTFSA-N eritoran Chemical compound O[C@H]1[C@H](OCCCCCCCCCC)[C@@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O[C@@H]1CO[C@H]1[C@H](NC(=O)CCCCCCCCC\C=C/CCCCCC)[C@@H](OCC[C@@H](CCCCCCC)OC)[C@H](OP(O)(O)=O)[C@@H](COC)O1 BPSMYQFMCXXNPC-MFCPCZTFSA-N 0.000 title 1
- 229950007107 eritoran Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261616784P | 2012-03-28 | 2012-03-28 | |
| US201361771339P | 2013-03-01 | 2013-03-01 | |
| PCT/US2013/028856 WO2013148072A1 (en) | 2012-03-28 | 2013-03-04 | Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL234777A true IL234777A (en) | 2017-02-28 |
Family
ID=47844539
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL234777A IL234777A (en) | 2012-03-28 | 2014-09-22 | Erythuran or its salts suitable for pharmacological use in the treatment of Orthomix virus infections |
| IL250201A IL250201A0 (en) | 2012-03-28 | 2017-01-19 | Administration of erythuran or its salts suitable for pharmaceutical use for the treatment of orthomyxovirus infections |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL250201A IL250201A0 (en) | 2012-03-28 | 2017-01-19 | Administration of erythuran or its salts suitable for pharmaceutical use for the treatment of orthomyxovirus infections |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9132141B2 (enExample) |
| EP (1) | EP2830631B1 (enExample) |
| JP (2) | JP6081574B2 (enExample) |
| KR (1) | KR20140139063A (enExample) |
| CN (1) | CN104321061B (enExample) |
| AU (1) | AU2013240456B2 (enExample) |
| BR (1) | BR112014024139A8 (enExample) |
| CA (1) | CA2868458A1 (enExample) |
| IL (2) | IL234777A (enExample) |
| MX (1) | MX358470B (enExample) |
| RU (1) | RU2636622C2 (enExample) |
| TW (1) | TWI594755B (enExample) |
| WO (1) | WO2013148072A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016090404A1 (en) * | 2014-12-08 | 2016-06-16 | The University Of Queensland | Methods and compositions for treating or preventing flavivirus infections |
| JP6778681B2 (ja) * | 2014-12-12 | 2020-11-04 | ザ ファインスタイン インスティテュート フォー メディカル リサーチ | Ｈｍｇｂ１媒介性炎症の治療 |
| WO2021207218A1 (en) * | 2020-04-06 | 2021-10-14 | Eisai R&D Management Co., Ltd. | Treatment of nidovirales infection with eritoran |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681824A (en) | 1995-06-05 | 1997-10-28 | Eisai Co., Ltd. | Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| US20030130212A1 (en) * | 1999-01-14 | 2003-07-10 | Rossignol Daniel P. | Administration of an anti-endotoxin drug by intravenous infusion |
| AU2001238507C9 (en) | 2000-02-18 | 2005-07-07 | Eisai R&D Management Co., Ltd. | Micelles |
| RU2289410C2 (ru) * | 2001-04-04 | 2006-12-20 | Корикса Корпорейшн | Профилактика и лечение инфекционных и других заболеваний с помощью соединений, основанных на моно- и дисахаридах |
| US7727974B2 (en) | 2001-08-10 | 2010-06-01 | Eisai R & D Management Co., Ltd. | Methods of reducing the severity of mucositis |
| AU2004218358A1 (en) * | 2003-03-05 | 2004-09-16 | Eisai R&D Management Co., Ltd. | Compositions and methods for preventing and treating endotoxin-related diseases and conditions |
| US20060211752A1 (en) * | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
| EP1879597A2 (en) * | 2005-05-13 | 2008-01-23 | Eisai Co., Ltd. | Lipid a analogs for treating oral and gastrointestinal mucositis |
| EP1895842A4 (en) * | 2005-06-17 | 2009-06-03 | Univ Rochester | METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE MEMORY BY BLOCKING INTRAHEPATIC ERASURE OF ACTIVE T CELLS |
| WO2007053455A2 (en) | 2005-10-28 | 2007-05-10 | Vaxinnate Corporation | Polypeptide ligans for toll-like receptor 4 (tlr4) |
| GB0605247D0 (en) * | 2006-03-15 | 2006-04-26 | Chiron Srl | Compositions and methods for immunisation |
| WO2007139150A1 (ja) | 2006-05-30 | 2007-12-06 | The University Of Tokushima | ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤 |
| CA2669674C (en) | 2006-11-22 | 2016-05-17 | Eisai R&D Management Co., Ltd. | Sodium salt of disaccharide compound, method for producing the same, and use of the same |
| US20110201569A1 (en) | 2009-09-16 | 2011-08-18 | Heidi Ehrentraut | Methods For Treating Myocardial Disorders |
-
2013
- 2013-03-04 BR BR112014024139A patent/BR112014024139A8/pt not_active Application Discontinuation
- 2013-03-04 TW TW102107459A patent/TWI594755B/zh not_active IP Right Cessation
- 2013-03-04 WO PCT/US2013/028856 patent/WO2013148072A1/en not_active Ceased
- 2013-03-04 AU AU2013240456A patent/AU2013240456B2/en not_active Ceased
- 2013-03-04 CA CA2868458A patent/CA2868458A1/en not_active Abandoned
- 2013-03-04 JP JP2015503225A patent/JP6081574B2/ja not_active Expired - Fee Related
- 2013-03-04 MX MX2014011520A patent/MX358470B/es active IP Right Grant
- 2013-03-04 EP EP13708644.3A patent/EP2830631B1/en not_active Not-in-force
- 2013-03-04 KR KR20147029799A patent/KR20140139063A/ko not_active Withdrawn
- 2013-03-04 CN CN201380027874.XA patent/CN104321061B/zh not_active Expired - Fee Related
- 2013-03-04 RU RU2014138880A patent/RU2636622C2/ru not_active IP Right Cessation
- 2013-03-04 US US13/783,580 patent/US9132141B2/en active Active
-
2014
- 2014-09-22 IL IL234777A patent/IL234777A/en not_active IP Right Cessation
-
2015
- 2015-07-31 US US14/815,451 patent/US20160022717A1/en not_active Abandoned
-
2017
- 2017-01-18 JP JP2017006555A patent/JP2017081993A/ja not_active Abandoned
- 2017-01-19 IL IL250201A patent/IL250201A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014011520A (es) | 2015-11-16 |
| BR112014024139A8 (pt) | 2018-01-16 |
| CN104321061A (zh) | 2015-01-28 |
| JP6081574B2 (ja) | 2017-02-15 |
| US9132141B2 (en) | 2015-09-15 |
| JP2015512397A (ja) | 2015-04-27 |
| IL250201A0 (en) | 2017-03-30 |
| US20130261076A1 (en) | 2013-10-03 |
| CN104321061B (zh) | 2017-10-24 |
| AU2013240456B2 (en) | 2017-04-13 |
| WO2013148072A1 (en) | 2013-10-03 |
| JP2017081993A (ja) | 2017-05-18 |
| US20160022717A1 (en) | 2016-01-28 |
| MX358470B (es) | 2018-08-22 |
| CA2868458A1 (en) | 2013-10-03 |
| EP2830631A1 (en) | 2015-02-04 |
| RU2636622C2 (ru) | 2017-11-24 |
| TW201402127A (zh) | 2014-01-16 |
| RU2014138880A (ru) | 2016-05-20 |
| BR112014024139A2 (pt) | 2017-06-20 |
| EP2830631B1 (en) | 2017-11-22 |
| KR20140139063A (ko) | 2014-12-04 |
| TWI594755B (zh) | 2017-08-11 |
| AU2013240456A1 (en) | 2014-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268987B (en) | Glaucoma treatment system | |
| ZA201405820B (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| IL234898A0 (en) | Systems for the treatment of pulmonary infections | |
| ZA201501018B (en) | Compounds for the treatment of paramoxyvirus viral infections | |
| SG11201503042QA (en) | Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections | |
| PH12014501045A1 (en) | Purine derivatives for the treatment of viral infections | |
| SG11201504813XA (en) | Mannose derivatives for treating bacterial infections | |
| PT3616695T (pt) | Ceftolozano/tazobactam para tratar infeções intrapulmonares | |
| IL253421B (en) | Compounds for the treatment of fibrosis (Leifat) | |
| GB201212588D0 (en) | Colicins for treating bacterial infections | |
| PL2858647T3 (pl) | Inhibitory receptora h4 do leczenia szumów usznych | |
| GB2521289B (en) | Formation treatment system | |
| PL2939665T3 (pl) | Kompozycja farmaceutyczna do leczenia zakażeń hiv | |
| EP2916767A4 (en) | DEVICES FOR TREATING TEETH NECKS | |
| GB201203180D0 (en) | Compounds for treating parvovirus infection | |
| IL234777A (en) | Erythuran or its salts suitable for pharmacological use in the treatment of Orthomix virus infections | |
| PT2864328T (pt) | Compostos farmaceuticamente ativos | |
| ZA201308116B (en) | Avian-based treatment for microbial infections | |
| IL236870B (en) | History of hydroxystatin for the treatment of osteoarthritis | |
| GB201119961D0 (en) | Antibacterial derivatives | |
| GB201119958D0 (en) | Antibacterial derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |